0000899243-22-009517.txt : 20220304 0000899243-22-009517.hdr.sgml : 20220304 20220304194616 ACCESSION NUMBER: 0000899243-22-009517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rahilly Sean CENTRAL INDEX KEY: 0001621195 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35503 FILM NUMBER: 22715864 MAIL ADDRESS: STREET 1: C/O ENOVA INTERNATIONAL, INC. STREET 2: 175 W. JACKSON BLVD. CITY: CHICAGO STATE: IL ZIP: 60604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enova International, Inc. CENTRAL INDEX KEY: 0001529864 STANDARD INDUSTRIAL CLASSIFICATION: PERSONAL CREDIT INSTITUTIONS [6141] IRS NUMBER: 453190813 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 WEST JACKSON BLVD. STREET 2: SUITE 1000 CITY: CHICAGO STATE: IL ZIP: 60604 BUSINESS PHONE: 312-568-4200 MAIL ADDRESS: STREET 1: 175 WEST JACKSON BLVD. STREET 2: SUITE 1000 CITY: CHICAGO STATE: IL ZIP: 60604 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-03 0 0001529864 Enova International, Inc. ENVA 0001621195 Rahilly Sean C/O ENOVA INTERNATIONAL, INC. 175 W. JACKSON BOULEVARD, SUITE 1000 CHICAGO IL 60604 0 1 0 0 General Counsel and Secretary Common stock, par value $0.00001 per share 2021-10-15 4 S 0 1430 36.5907 D 80127 D Stock Option (right to buy) with limited SAR 31.98 2021-08-03 4 A 0 4504 0.00 A 2028-08-03 Common stock, par value $0.00001 per share 4504 112401 D Stock Option (right to buy) with limited SAR 35.75 2021-11-04 4 A 0 4580 0.00 A 2028-11-04 Common stock, par value $0.00001 per share 4580 116981 D The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025. /s/ Sean Rahilly 2022-03-04